tykhr
sign in
free sign up
Alnylam Pharmaceuticals Inc
Biotechnology
Healthcare
ALNY
129 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
220.33
52 week high
300.55
high
245.56
52 week low
152.78
low
205.87
growth
63.90 %
previous Close
224.32
P/E ratio
market cap
31.25 B
div yield
0
usd
Sep 2024
qoq
revenue
501 M
-24.08 %
net incoming
-111.57 M
-560.61 %
eps
0.00 %
-569.23 %
eps surprise
6.45 %
net profit margin
-22.27 %
-19.00 %
operating incoming
-76.91 M
-258.20 %
net change in cash
134 M
-53.24 %
cash on hand
1.10 B
13.57 %
cost of revenue
85.91 M
25.09 %
top